Health Care/Hospital
Ascletis' ASC36_35FDC Demonstrated Potential for Once-Monthly to Once-Quarterly Dosing and Robust Weight-Loss in Preclinical Studies Presented at EASD 2026
HONG KONG, Oct. 2, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announced the presentation of key preclinical data for its ASC36_35FDC (ASC36_35 co-formulation) at the 62nd European Association for the Study of Diabetes (EASD) Annual Meeting, being held September 28–Oc...
2026-10-02 17:00
Lundbeck to showcase progress across its movement disorders pipeline with data in multiple system atrophy and Parkinson's disease at MDS® 2026
* Late-breaking Phase III MASCOT oral presentation will characterize the clinical profile and diversity of participants in Lundbeck's ongoing global Phase III trial investigating amlenetug in multiple system atrophy (MSA) * New research across clinical trial endpoints, biomarkers, diagnostic t...
2026-10-02 15:05
418
Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs
Includes worldwide license to ABO2203, Abogen's mRNA-encoded CD19xCD3 T-Cell Engager Agreement also gives Novartis exclusive options to license other potential programs leveraging Abogen's RNA proprietary platform SUZHOU, China, Oct. 2, 2026 /PRNewswire/ -- Abogen Biosciences ("Abogen" or the ...
2026-10-02 12:42
1084
I Peace Selected as a TOP 10 Awardee for the "Top 10 Longevity Breakthrough Awards 2026"
PALO ALTO, Calif., Oct. 1, 2026 /PRNewswire/ -- I Peace Inc., a biotech company pioneering induced pluripotent stem cell (iPScell) technologies for regenerative medicine and longevity, today announced that it was selected as one of the awardees for the Top 10 Longevity Breakthrough Awards at the ...
2026-10-02 06:10
862
ENA Members Choose Vanessa Gorman as 2027 President-elect
Secretary/treasurer, two board members also picked in annual election SCHAUMBURG, Ill., Oct. 2, 2026 /PRNewswire/ -- A believer in the power of connecting people and building the community of emergency and forensic nurses, Vanessa Gorman, DNP, MSN, RN, CCRN, FAEN, FCENA, of Australia, has been ch...
2026-10-02 04:30
981
Momcozy Announces $100,000 Scholarship Fund to Expand Access to Perinatal Mental Health Certification
LOS ANGELES, Oct. 1, 2026 /PRNewswire/ -- Momcozy, a leading global brand supporting women and families through pregnancy and motherhood, has partnered with Postpartum Support International (PSI) to establish a $100,000 scholarship fund designed to expand access to professional perinatal mental h...
2026-10-02 00:00
2288
Five Years of Purposeful Fashion: LILYSILK Renews Partnership with National Breast Cancer Foundation for 'A Bloom of Care' Campaign
NEW YORK, Oct. 1, 2026 /PRNewswire/ -- LILYSILK, the world's leading silk brand
dedicated to inspiring people to live spectacularly, announced the renewal of
its partnership withNational Breast Cancer Foundation, Inc.® (NBCF)
2026-10-01 22:00
3580
A Formidable Type of Childhood Cancer Gets Added to Highly Regarded Library of Treatment Recommendations
New NCCN Guidelines for Pediatric Bone Sarcoma focus on how to provide the best care possible for children and adolescents with Ewing sarcoma. PLYMOUTH MEETING, Pa., Oct. 1, 2026 /PRNewswire/ -- Today, the National Comprehensive Cancer Network® (NCCN®) published the first-ever edition of NCCN Cl...
2026-10-01 21:44
2911
Bambusa Therapeutics Initiates Subcutaneous Dosing of BBT001 in Atopic Dermatitis, Following Compelling Intravenous Proof-of-Concept Data
First patient dosed as Bambusa expands global development of its long-acting bispecific antibody targeting both IL-4Rα and IL-31 High-concentration subcutaneous formulation designed to combine BBT001's emerging profile of rapid, deep and durable clinical activity with convenient administration a...
2026-10-01 21:00
2244
Advances in Digital Therapeutics and HoneyNaps AI Enhance Clinical Trial Efficiency
* Supporting pharmaceutical, medical device, wellness, and research organizations in obtaining standardized sleep data * Expanding the use of SOMNUM scoring technology to provide clinical analysis services tailored to each customer's research objectives * AI Technologies Supporting Global...
2026-10-01 19:00
2166
PeKa B40 Screenings Reveal Undiagnosed Conditions Among Almost Half of Participants
STR recipients and their spouses aged 40 and above urged to use their free health-screening benefit at participating clinics nationwide. CYBERJAYA, Malaysia, Oct. 1, 2026 /PRNewswire/ -- Of the 328,302 people who underwent health screening through PeKa B40 in 2025, 44.5% were found to have at le...
2026-10-01 12:22
1127
Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth
SINGAPORE, Oct. 1, 2026 /PRNewswire/ -- Emerald
2026-10-01 11:00
3416
IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution
SYDNEY, Oct. 1, 2026 /PRNewswire/ -- IMG
2026-10-01 09:08
957
Health In Tech Launches HitRix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance
AI-powered HitRix platform streamlines large-group submissions, multi-market quoting, proposal comparison and placement in one secure environment, thereby reducing time to market. STUART, Fla., Sept. 30, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform co...
2026-10-01 04:00
3322
Suvoda's latest platform release creates a global experience across study data, patient engagement, scheduling, payments, and clinical trial operations
CONSHOHOCKEN, Pa., Sept. 30, 2026 /PRNewswire/ -- Suvoda
2026-09-30 22:00
1942
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
* Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. * The development and manufacturing activities are being conducted at Piramal's dedicated sterile injectable facility in Lexington, Kentucky. * This partnership addresse...
2026-09-30 21:54
1379
Phrontline Biopharma Doses First Patient in Global Phase I/II Trial of TJ102, an FRα × CDH6 Bispecific Dual-Payload ADC
First clinical program built on Phrontline's DLP1 branched dual-payload linker platform HANGZHOU, China and SHANGHAI, Sept. 30, 2026 /PRNewswire/ -- Phrontline Biopharma, a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs), today announced that the f...
2026-09-30 21:53
1438
The 94th CMEF, the World's Leading Medical Device Industry Event, Set to Open in Beijing Oct. 21-24
BEIJING, Sept. 30, 2026 /PRNewswire/ -- The 94th China International Medical Equipment Fair (CMEF) and concurrent events—including ICMD, covering medical device design and manufacturing; CRS, focusing on rehabilitation and assistive technology; CECN, dedicated to elderly care and nursing; and Hea...
2026-09-30 21:16
961
Yuyu Pharma Brings Ari's Purrfect to Amazon Accelerate 2026
Korean pharmaceutical company explores Amazon AI and seller tools to grow its U.S. feline-health brand SEOUL, South Korea, Sept. 30, 2026 /PRNewswire/ -- Robert Wonsang Yu, CEO of Yuyu Pharma (KRX: 000220), attended Amazon Accelerate 2026 in Seattle from September 22 to 24 to explore how Amazon'...
2026-09-30 21:00
860
Joint Commission International Honors Healthcare Organizations and National Health Authorities with Inaugural Global Patient Safety Awards
OAK BROOK TERRACE, Ill., Sept. 30, 2026 /PRNewswire/ -- Joint Commission
International (JCI) recognized the winners of the inaugural Global Patient
Safety Awards today atUNIFY 2026™: Convening for Quality
2026-09-30 21:00
792
Week's Top Stories
Most Reposted
Responsible Fintech Institute Appoints Four Executive Fellows and Elevates Distinguished Professor Patrick H. M. Loh to Co-Founder
[Picked up by 279 media titles]
2026-09-29 09:00
HLB's Flagship CIO Fund Launched with Strategic Alliance with Lombard Odier
[Picked up by 278 media titles]
2026-09-28 23:04
Malaysia Calls for Shift from Halal-Certified to Halal-Competitive as ASEAN Targets USD5 Trillion Global Halal Economy
[Picked up by 277 media titles]
2026-09-25 14:45
Nuix Recognised as a RiskTech100® 2027 Disruptor by Chartis Research
[Picked up by 274 media titles]
2026-09-25 08:30Allianz Partners unveils next-generation travel insurance platform to help partners navigate changing landscape
[Picked up by 269 media titles]
2026-09-28 07:30
Most Read
Brightray Signs Prefabricated Module Sales Framework Agreement for Planned 40MW AI Data Center Project in Macao
2026-09-25 20:30
14270
Envision Energy Secures TÜV SÜD Certificate for Wind Farm Control System, Strengthening Long-Term Resilience for Future Energy Systems
2026-09-25 20:11
12958
ULTRALOQ Launches Next-Generation Smart Lock Collection: Refining Home Entry with Natural, Intelligent and Trusted Access Solutions
2026-09-26 02:46
12102
